FINWIRES · TerminalLIVE
FINWIRES

Pulsar Helium Acquires Strategic Surface Land at Topaz Helium Project, Minnesota

By

Pulsar Helium (PLSR.V) has acquired approximately 1,360 acres of surface land in Lake County, Minnesota, located within its flagship Topaz Project, the company said on Friday.

The surface land was purchased in an arm's length transaction from Wolf Lands Inc. for total cash consideration of US$2.48 million to be satisfied through the company's existing cash resources, said the company.

The newly acquired land lies within the mineral rights that the company holds under lease from a separate private owner, and the area includes the location of the company's Jetstream #7 (JS#7) well, added the company.

The acquisition forms part of Pulsar's "broader push toward production readiness at Topaz", said the company and added that it recently concluded its Jetstream exploration and appraisal program, with all wells drilled to date having encountered gas under high pressure and is now obtaining quotes for the drilling of up to four new production wells to supplement two production-ready wells already drilled.

"This Acquisition, driven by our intention to develop Topaz into a significant primary helium producer, builds on growing momentum at the project as we move decisively toward production readiness," said Thomas Abraham-James, CEO of Pulsar. "It also follows recent legislative progress updating Minnesota's permitting framework for helium extraction. With a clearer pathway now emerging toward future production, securing ownership of the surface land overlying our leased mineral rights, including the site of our Jetstream #7 well, provides Pulsar with increased operational control and long-term development certainty as we continue advancing Topaz toward production."

Related Articles

Mining & Metals

Spectral Medical Submits PMX Premarket Approval Application to FDA

Spectral Medical (EDT.TO) has submitted its premarket approval (PMA) application to the U.S. Food and Drug Administration for PMX, the company said on Friday.PMX is Spectral's endotoxin removal therapy for patients with endotoxic septic shock (ESS). The submission is supported by data from the company's Tigris trial, a Phase 3 follow-on study evaluating PMX in patients with ESS. Complete results of the Tigris trial out to 90 days were published last March in the journal The Lancet Respiratory Medicine."This PMA submission represents a defining milestone for Spectral and reflects years of focused clinical, regulatory and operational execution," said chief executive Chris Seto."We believe the totality of evidence supporting PMX demonstrates that a targeted therapy for endotoxic septic shock is beneficial. This is an area of critical unmet medical need with limited therapeutic innovation over the past several decades."Spectral Medical shares closed down $0.02, to $1.40, on Thursday, on the Toronto Stock Exchange.

$EDT.TO
Mining & Metals

Canopy Growth Relaunches Tweed Brand in Germany With New MTL Cannabis Strain Lineup

Canopy Growth (WEED.TO, CGC) relaunched Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by its unit MTL Cannabis (MTL), it said on Friday.The initial launch includes "Pablo's Revenge, Dante'z Inferno, and Frost'd Flakes" cultivars. Up to five MTL-derived strains are expected to be introduced in June 2026, with further portfolio expansion planned throughout the year, it said.The company also announced that it has been granted a management cease trade order effective as of May 28, by its principal regulator, the Ontario Securities Commission, following its announcement on May 15, regarding certain non-cash technical errors in its accounting. Canopy Growth intends to refile the relevant financial statements in its Annual Report on Form 10-K for the fiscal year ended March 31, 2026, it said.U.S.-listed shares of the company were last seen unchanged at US$1.12 in pre-market trading.

$HMMJ.TO$WEED.TO
Mining & Metals

Charlotte's Web Holdings Strengthens Balance Sheet After Closing Transactions with British American Tobacco

Charlotte's Web Holdings (CWEB.TO) has strengthened its balance sheet and enhanced its capital position after closing transactions with British American Tobacco subsidiary BT DE Investments (BAT), Charlotte's Web said overnight Thursday.Charlotte's Web, a provider of hemp extract wellness products, closed the amendment and conversion of BAT's outstanding C$75.3 million principal amount of the convertible debenture into common shares of Charlotte's Web at a conversion price of C$0.94 per share.Charlotte's Web also completed a concurrent additional equity investment by BAT of US$10 million through a private placement priced at C$0.94 per share.The company plans to use the proceeds from the private placements for its participation in the anticipated CMMI Medicare pilot program and other medical channel initiatives.The program creates a pathway for eligible Medicare beneficiaries to access cannabidiol products through consultation with their physician."With increased financial flexibility and a streamlined capital structure, we are better positioned to execute our growth strategy, expand access, and deliver long-term value for our shareholders," Chief Executive Officer Bill Morachnick said.

$CWEB.TO$HMMJ.TO